awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26827975-E719F99D-4F67-4EA8-A68C-D5E8D9CEBA56
Q26827975-E719F99D-4F67-4EA8-A68C-D5E8D9CEBA56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-E719F99D-4F67-4EA8-A68C-D5E8D9CEBA56
Growth factor and signaling pathways and their relevance to prostate cancer therapeutics
P2860
Q26827975-E719F99D-4F67-4EA8-A68C-D5E8D9CEBA56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26827975-E719F99D-4F67-4EA8-A68C-D5E8D9CEBA56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8393c84968ea08309dcb1a0ce25ea2c8d460df7e
P2860
Phase I, dose-escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors.